Phase 3 PCOS Clinical Trials

3 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–3 of 3 trials

Recruiting

Phase 3

Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome

ObesePCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

University of Colorado, Denver80 enrolled1 locationNCT05819853

Recruiting

Phase 2Phase 3

Semaglutide in Women With Polycystic Ovary Syndrome and Obesity

ObesityPolycystic Ovary Syndrome (PCOS) Women

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh30 enrolled1 locationNCT06896981

Completed

Phase 3Phase 4

Gonadotropin-releasing hormone (GnRH) antagonist vs. gonadotropin-releasing hormone agonist protocol for in vitro fertilization in non-obese patients with Polycystic Ovary Syndrome (PCOS). A prospective randomized study.

GnRH antagonists in PCOS

State Committee for Scientific Research70 enrolled1 locationACTRN12607000636459